申请人:Ajinomoto Co., Inc.
公开号:EP0479601A2
公开(公告)日:1992-04-08
A piperidine derivative of general formula (I) or a pharmaceutically acceptable salt thereof :
wherein
is any of several specified aromatic-containing groups ; X is selected from one of several hetero atom-containing groups or C2 alkylene or a cyano-containing group ; and
Q is phenyl, cyclohexyl, piperidinyl, tetrahydropyranyl, pyridyl, pyrrolyl, N-methylpyrrolyl, thienyl, furyl, 1-hexyl, or cyano ;
from 1 to 3 hydrogen atoms in Q may be independently substituted by alkyl of from 1 to 3 carbon atoms, perfluoroalkyl of from 1 to 3 carbon atoms, acylamino of from 1 to 6 carbon atoms, perfluoroacylamino of from 1 to 3 carbon atoms, alkoxy of from 1 to 3 carbon atoms, alkanesulfonylamino of from 1 to 3 carbon atoms, perfluoroalkanesulfonylamino of from 1 to 3 carbon atoms, acetoxy of from 1 to 3 carbon atoms, aminocarbonyl, aminosulfonyl, fluoro, chloro, cyano, hydroxy, nitro, amino, imidazolylmethyl, cinnamoylamino, p-fluorobenzoyl, cyanomethyl, cyanoethyl, methoxyacetoxy, alkoxycarbonyl of from 1 to 3 carbon atoms ;
1 is an integer of from 0 to 1 ;
m is an integer of from 0 to 1 ;
n is an integer of from 0 to 6.
The derivatives are useful as antiarrhythmic agents.
通式(I)的哌啶衍生物或其药学上可接受的盐:
其中
是几个指定的含芳香族基团中的任一个; X 选自几个含杂原子基团或 C2 亚烷基或含氰基团中的任一个;以及
Q 是苯基、环己基、哌啶基、四氢吡喃基、吡啶基、吡咯基、N-甲基吡咯基、噻吩基、呋喃基、1-己基或氰基;
Q 中的 1 至 3 个氢原子可独立地被 1 至 3 个碳原子的烷基、1 至 3 个碳原子的全氟烷基、1 至 6 个碳原子的酰氨基、1 至 3 个碳原子的全氟酰氨基、1 至 3 个碳原子的烷氧基、1 至 3 个碳原子的烷磺酰氨基取代、1 至 3 个碳原子的全氟烷磺酰氨基、1 至 3 个碳原子的乙酰氧基、氨基羰基、氨基磺酰基、氟基、氯基、氰基、羟基、硝基、氨基、咪唑基甲基、肉桂酰氨基、对氟苯甲酰基、氰甲基、氰乙基、甲氧基乙酰氧基、1 至 3 个碳原子的烷氧羰基;
1 是 0 至 1 的整数;
m 是 0 至 1 的整数;
n 是 0 至 6 的整数。
这些衍生物可用作抗心律失常药物。